Literature DB >> 6800439

Insulin given intranasally induces hypoglycaemia in normal and diabetic subjects.

A E Pontiroli, M Alberetto, A Secchi, G Dossi, I Bosi, G Pozza.   

Abstract

Regular or crystalline insulin with sodium glycocholate as surfactant administered intranasally to normal volunteers induced hypoglycaemia and an increase in serum immunoreactive insulin concentrations. Serum C-peptide concentrations decreased or remained unchanged. Insulin administered intravenously to three of these subjects yielded a potency ratio of 1:8 for intranasal and intravenous insulin. In four insulin-dependent diabetics a cross-over study was performed on different days, insulin being administered once intranasally and once subcutaneously in a ratio of 1:9. In these patients the intranasal insulin was more effective than the subcutaneous insulin in preventing hyperglycaemia after breakfast. In four other insulin-dependent diabetics 11-hours monitoring was performed twice on two different days, insulin being administered in divided dosage sufficient to achieve a reasonable glycaemic profile. The administration during the morning, whereas subcutaneous insulin was more effective than intranasal during the afternoon.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6800439      PMCID: PMC1495887          DOI: 10.1136/bmj.284.6312.303

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  8 in total

1.  Immunoassay of insulin with insulin-antibody precipitate.

Authors:  C N HALES; P J RANDLE
Journal:  Biochem J       Date:  1963-07       Impact factor: 3.857

2.  Nasal absorption of insulin in dogs.

Authors:  S Harai; T Ikenaga; T Matsuzawa
Journal:  Diabetes       Date:  1978-03       Impact factor: 9.461

3.  Comparison of plasma levels of luteinizing hormone releasing hormone in men after intravenous or intranasal administration.

Authors:  G Fink; G Gennser; P Liedholm; J Thorell; J Mulder
Journal:  J Endocrinol       Date:  1974-11       Impact factor: 4.286

4.  Insulin: intestinal absorption as water-in-oil-in-water emulsions.

Authors:  R H Engel; S J Riggi; M J Fahrenbach
Journal:  Nature       Date:  1968-08-24       Impact factor: 49.962

5.  Absorption of insulin from the human small intestine.

Authors:  C W Crane; G R Luntz
Journal:  Diabetes       Date:  1968-10       Impact factor: 9.461

6.  Radioimmunological determination of human C-peptide in serum.

Authors:  L G Heding
Journal:  Diabetologia       Date:  1975-12       Impact factor: 10.122

7.  Development and evaluation of a glucose analyzer for a glucose controlled insulin infusion system ((Biostator).

Authors:  E J Fogt; L M Dodd; E M Jenning; A H Clemens
Journal:  Clin Chem       Date:  1978-08       Impact factor: 8.327

8.  Human insulin produced by recombinant DNA technology: safety and hypoglycaemic potency in healthy men.

Authors:  H Keen; A Glynne; J C Pickup; G C Viberti; R W Bilous; R J Jarrett; R Marsden
Journal:  Lancet       Date:  1980-08-23       Impact factor: 79.321

  8 in total
  24 in total

1.  The molecular weight dependence of nasal absorption: the effect of absorption enhancers.

Authors:  M D Donovan; G L Flynn; G L Amidon
Journal:  Pharm Res       Date:  1990-08       Impact factor: 4.200

Review 2.  Recent developments in insulin delivery techniques. Current status and future potential.

Authors:  F P Kennedy
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

Review 3.  The nasal mucociliary clearance: relevance to nasal drug delivery.

Authors:  N G Schipper; J C Verhoef; F W Merkus
Journal:  Pharm Res       Date:  1991-07       Impact factor: 4.200

4.  Intranasal insulin therapy: the clinical realities.

Authors:  J Hilsted; S Madsbad; A Hvidberg; M H Rasmussen; T Krarup; H Ipsen; B Hansen; M Pedersen; R Djurup; B Oxenbøll
Journal:  Diabetologia       Date:  1995-06       Impact factor: 10.122

Review 5.  Intranasal drug delivery. Potential advantages and limitations from a clinical pharmacokinetic perspective.

Authors:  A E Pontiroli; A Calderara; G Pozza
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

6.  Intranasal calcitonin and plasma calcium concentrations in normal subjects.

Authors:  A E Pontiroli; M Alberetto; G Pozza
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-11

7.  Metabolic effects of intranasally administered glucagon: comparison with intramuscular and intravenous injection.

Authors:  A E Pontiroli; M Alberetto; G Pozza
Journal:  Acta Diabetol Lat       Date:  1985 Apr-Jun

8.  Pharmacokinetics and pharmacodynamics of intranasal insulin spray (Nasulin) administered to healthy male volunteers: infuence of the nasal cycle.

Authors:  Andrew C Leary; Muiris Dowling; Kathleen Cussen; Jackie O'Brien; Robert M Stote
Journal:  J Diabetes Sci Technol       Date:  2008-11

9.  The effects of permeation enhancers on the surface morphology of the rat nasal mucosa: a scanning electron microscopy study.

Authors:  R D Ennis; L Borden; W A Lee
Journal:  Pharm Res       Date:  1990-05       Impact factor: 4.200

10.  Intranasal administration of gentamicin in human subjects.

Authors:  A Rubinstein
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.